SK Saha, A Joshi, R Singh, K Dubey - Pharmaceutical …, 2023 - Taylor & Francis
Evolving therapeutic landscape through combinatorial chemistry and high throughput screening have resulted in an increased number of poorly soluble drugs. Drug delivery …
Poor bioavailability hampers the use of curcumin and piperine as biologically active agents. It can be improved by enhancing the solubility as well as by using bioenhancers to inhibit …
The low bioaccessibility of hesperetin and piperine hampers their application as therapeutic agents. Piperine has the ability to improve the bioavailability of many compounds when co …
WH Khan, S Asghar, IU Khan, M Irfan, A Alshammari… - Heliyon, 2023 - cell.com
BCS class II drugs exhibit low aqueous solubility and high permeability. Such drugs often have an incomplete or erratic absorption profile. This study aimed to predict the effects of β …
SA Alanazi, SS Imam, S Alshehri, MM Alanazi… - Journal of Drug Delivery …, 2024 - Elsevier
Naringin (NRG) is a water insoluble glycoside having wide range of therapeutic efficacy. Its efficacy is limited due to its poor water solubility and bioavailability. In the current research …
NW Mohamed, SA Sabry, MA Mahdy… - Journal of Drug Delivery …, 2024 - Elsevier
Irbesartan (IRB), a selective AT1 subtype angiotensin II receptor blocker used for management of hypertension, exhibiting low and variable oral bioavailability because of its …
Y Turanlı, M Birer, YT Birer, R Uyar, BY Dikmen… - Journal of Drug Delivery …, 2024 - Elsevier
Risperidone is an antipsychotic drug classified as BCS Class II with low solubility at physiological pH and orally used in the treatment of schizophrenia. Electrospinning is one of …
A Bhatkande, S Narala, H Wang, N Narala… - Journal of …, 2024 - Springer
Purpose The current study assessed the potential of a pneumatic 3D printer in developing a taste-masked tablet in a single step. Metronidazole (MTZ) was chosen as the model drug …
N Georgiou, E Chontzopoulou, EA Routsi… - ACS …, 2024 - ACS Publications
The rational design of AT1 receptor antagonists represents a pivotal approach in the development of therapeutic agents targeting cardiovascular pathophysiology. Sartans, a …